semaglutide for liver disease Landmark Study Finds Effectively Treats Serious : ScienceAlert Novo Nordisk's Wegovy gets accelerated

In a Phase II study reported in 2024 involving 168 patients with NASH, moderate to advanced fibrosis (F2F3), and NAS 4, a significantly greater proportion of patients in the denifanstat group achieved the primary endpoint compared with placebo, with statistically meaningful improvements in fibrosis as well

This mimics the effects of the hormone amylin and can also slow down stomach emptying, decrease glucagon secretion after meals, and control appetite

What You Need to Know About Tirzepatide Tirzepatide acts by stimulating two hormonal pathways naturally occurring in your body: GLP-1 and GIP

multiple controlled trials Dose: 12mg/day subQ Stack synergy: Reta handles appetite/energy balance

This distinction relates to how the medication is made, not how the drug works in the body